litlas
Log inCreate account

Brad H. Nelson

Active 1994–2025

95
Papers
19,000
Citations
64
h-index
92
i10-index

Citations

Citations per year for Brad H. Nelson1990: 1 citations1994: 3 citations1995: 25 citations1996: 12 citations1997: 7 citations1998: 5 citations1999: 10 citations2000: 33 citations2001: 62 citations2002: 67 citations2003: 57 citations2004: 64 citations2005: 51 citations2006: 62 citations2007: 44 citations2008: 58 citations2009: 36 citations2010: 40 citations2011: 65 citations2012: 89 citations2013: 130 citations2014: 116 citations2015: 156 citations2016: 255 citations2017: 214 citations2018: 280 citations2019: 802 citations2020: 1,000 citations2021: 1,116 citations2022: 934 citations2023: 654 citations2024: 1,027 citations2025: 529 citations2026: 12 citations1991–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,662 citing papers, 25.1% of this breakdownChina: 1,601 citing papers, 15.1% of this breakdownUnited Kingdom: 566 citing papers, 5.3% of this breakdownCanada: 525 citing papers, 5% of this breakdownGermany: 479 citing papers, 4.5% of this breakdownFrance: 418 citing papers, 4% of this breakdownItaly: 404 citing papers, 3.8% of this breakdownAustralia: 340 citing papers, 3.2% of this breakdownJapan: 329 citing papers, 3.1% of this breakdownNetherlands: 291 citing papers, 2.8% of this breakdownSwitzerland: 242 citing papers, 2.3% of this breakdownSpain: 215 citing papers, 2% of this breakdown
0%25.1%Other 23.8%

Institutions

Fields

  • Medicine54%
  • Biochemistry, Genetics and Molecular Biology21.6%
  • Immunology and Microbiology20%
  • Computer Science1.3%
  • Engineering1%
  • Neuroscience0.6%
  • Other1.5%

Topics

  • Cancer Immunotherapy and Biomarkers12.7%
  • Immunotherapy and Immune Responses8.7%
  • Immune Cell Function and Interaction7.6%
  • CAR-T cell therapy research5.3%
  • T-cell and B-cell Immunology3.8%
  • Immune cells in cancer3.2%
  • Other58.7%

Coauthors

All papers

Open in search
  1. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities

    Authors: Céline M. Laumont, Allyson C. Banville, Mara Gilardi, Daniel P. Hollern, Brad H. Nelson - Nature reviews. Cancer 2022 cited by 513

  2. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer

    Authors: David R. Kroeger, Katy Milne, Brad H. Nelson - Clinical Cancer Research 2016 cited by 606

  3. Cancer stemness, intratumoral heterogeneity, and immune response across cancers

    Authors: Alex Miranda, Phineas T. Hamilton, Allen W. Zhang, Swetansu Pattnaik, Étienne Becht, Artur Mezheyeuski, Jarle Bruun, Patrick Micke, Aurélien de Reyniès, Brad H. Nelson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 607

  4. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

    Authors: David D.L. Bowtell, Steffen Böhm, Ahmed A. Ahmed, Paul‐Joseph Aspuria, Robert C. Bast, Valerie Beral, Jonathan S. Berek, Michael J. Birrer, Sarah P. Blagden, Michael A. Bookman, James D. Brenton, Katherine B. Chiappinelli, Filipe Correia Martins, George Coukos, Ronny Drapkin, Richard J. Edmondson, Christina Fotopoulou, Hani Gabra, Jérôme Galon, Charlie Gourley, Valerie Heong, David G. Huntsman, Marcin Iwanicki, Beth Y. Karlan, Allyson Kaye, Ernst Lengyel, Douglas A. Levine, Karen H. Lu, Iain A. McNeish, Usha Menon, Steven A. Narod, Brad H. Nelson, Kenneth P. Nephew, Paul D.P. Pharoah, Daniel J. Powell, Pilar Ramos, Iris L. Romero, Clare L. Scott, Anil K. Sood, Euan A. Stronach, Frances R. Balkwill - Nature reviews. Cancer 2015 cited by 1,425

  5. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver, Mónica V. Estrada, Paula I. González-Ericsson, Melinda Sanders, Benjamin Solomon, Cinzia Solinas, Gert G. G. M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes A. Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nucíforo, Laura Comerma, E. Aubrey Thompson, Sunil R. Lakhani, Seong-Rim Kim, Stuart J. Schnitt, Cécile Colpaert, Christos Sotiriou, Stefan Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  6. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity

    Authors: Céline M. Laumont, Brad H. Nelson - Cancer Cell 2023 cited by 227

  7. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

    Authors: Wouter Scheper, Sander Kelderman, Lorenzo F. Fanchi, Carsten Linnemann, Gavin Bendle, Marije A. J. de Rooij, Christian Hirt, Riccardo Mezzadra, Maarten Slagter, Krijn K. Dijkstra, Roelof J.C. Kluin, Pétur Snæbjörnsson, Katy Milne, Brad H. Nelson, Henry Zijlmans, Gemma G. Kenter, Emile E. Voest, John B.A.G. Haanen, Ton N. Schumacher - Nature Medicine 2018 cited by 579

  8. Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer

    Authors: Maartje C.A. Wouters, Brad H. Nelson - Clinical Cancer Research 2018 cited by 523

  9. Oncolytic viruses as engineering platforms for combination immunotherapy

    Authors: Kwame Twumasi‐Boateng, Jessica L. Pettigrew, Young Kwok, John C. Bell, Brad H. Nelson - Nature reviews. Cancer 2018 cited by 416

  10. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Authors: Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver, Mónica V. Estrada, Paula I. González-Ericsson, Melinda E. Sanders, Benjamin Solomon, Cinzia Solinas, Gert G. G. M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes A. Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nucíforo, Laura Comerma, E. Aubrey Thompson, Sunil R. Lakhani, Seong-Rim Kim, Stuart J. Schnitt, Cécile Colpaert, Christos Sotiriou, Stefan Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 720

  11. CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer

    Authors: Julie S. Nielsen, Rob A. Sahota, Katy Milne, Sara E. Kost, Nancy J. Nesslinger, Peter H. Watson, Brad H. Nelson - Clinical Cancer Research 2012 cited by 547

  12. Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer

    Authors: Allen W. Zhang, Andrew McPherson, Katy Milne, David R. Kroeger, Phineas T. Hamilton, Alex Miranda, Tyler Funnell, Nicole S. Little, Camila P. E. de Souza, Sonya Laan, Stacey Ledoux, Dawn R. Cochrane, Jamie Lim, Winnie Yang, Andrew Roth, Maia A. Smith, Julie Ho, Kane Tse, Thomas Zeng, Inna Shlafman, Michael R. Mayo, Richard A. Moore, Henrik Failmezger, Andreas Heindl, Yi Kan Wang, Ali Bashashati, Diljot Grewal, Scott D. Brown, Daniel Lai, Adrian Wan, Cydney Nielsen, Curtis Huebner, Basile Tessier‐Cloutier, Michael S. Anglesio, Alexandre Bouchard‐Côté, Yinyin Yuan, Wyeth W. Wasserman, C. Blake Gilks, Anthony N. Karnezis, Samuel Aparício, Jessica N. McAlpine, David G. Huntsman, Robert A. Holt, Brad H. Nelson, Sohrab P. Shah - Cell 2018 cited by 387

  13. B cells and cancer

    Authors: Víctor H. Engelhard, José R. Conejo-García, Rafi Ahmed, Brad H. Nelson, Karen Willard‐Gallo, Tullia C. Bruno, Wolf H. Fridman - Cancer Cell 2021 cited by 113

  14. Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer

    Authors: John R. Webb, Katy Milne, Peter H. Watson, Ronald J. deLeeuw, Brad H. Nelson - Clinical Cancer Research 2013 cited by 418

  15. Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

    Authors: Katy Milne, Martin Köbel, Steven E. Kalloger, Rebecca Barnes, Dongxia Gao, C. Blake Gilks, Peter H. Watson, Brad H. Nelson - PLoS ONE 2009 cited by 435

  16. Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

    Authors: Tomohiro Aoki, Lauren C. Chong, Katsuyoshi Takata, Katy Milne, Monirath Hav, Anthony Colombo, Elizabeth A. Chavez, Michael Nissen, Xuehai Wang, Tomoko Miyata‐Takata, Vivian Lam, Elena Viganò, Bruce W. Woolcock, Adèle Telenius, Michael Y. Li, Shannon Healy, Chanel Ghesquiere, Daniël Kos, Talia Goodyear, J. E. Veldman, Allen W. Zhang, Jubin Kim, Saeed Saberi, Jiarui Ding, Pedro Farinha, Andrew P. Weng, Kerry J. Savage, David W. Scott, Gerald Krystal, Brad H. Nelson, Anja Mottok, Akil Merchant, Sohrab P. Shah, Christian Steidl - Cancer Discovery 2019 cited by 226

  17. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Authors: Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon, Ashish Sharma, Jennifer K. Kerner, Carsten Denkert, Yinyin Yuan, Khalid AbdulJabbar, Stephan Wienert, Peter Savas, Leonie Voorwerk, Andrew H. Beck, Anant Madabhushi, Johan Hartman, Manu Sebastian, Hugo M. Horlings, Jan Hudeček, Francesco Ciompi, David Moore, Rajendra Singh, Elvire Roblin, Marcelo Luiz Balancin, Marie‐Christine Mathieu, Jochen K. Lennerz, Pawan Kirtani, I‐Chun Chen, Jeremy Braybrooke, Giancarlo Pruneri, Sandra Demaria, Sylvia Adams, Stuart J. Schnitt, Sunil R. Lakhani, Federico Rojo, Laura Comerma, Sunil Badve, Mehrnoush Khojasteh, W. Fraser Symmans, Christos Sotiriou, Paula I. González-Ericsson, Katherine L. Pogue–Geile, Rim S. Kim, David L. Rimm, Giuseppe Viale, Stephen M. Hewitt, John M. S. Bartlett, Frédérique Penault–Llorca, Shom Goel, Huang‐Chun Lien, Sibylle Loibl, Zuzana Kos, Sherene Loi, Matthew G. Hanna, Stefan Michiels, Marleen Kok, Torsten O. Nielsen, Alexander J. Lazar, Zsuzsanna Bagó-Horváth, Loes Kooreman, Jeroen van der Laak, Joel Saltz, Brandon D. Gallas, Uday Kurkure, Michael Barnes, Roberto Salgado, Lee Cooper, International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair M. Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo, Anna Sapino, André L. Moreira, Andrea L. Richardson, Andrea Vingiani, Andrew M. Bellizzi, Andrew Tutt, Ángel Guerrero‐Zotano, Anita Grigoriadis, Anna Ehinger, Ana C. Garrido-Castro, Anne Vincent-Salomon, Anne‐Vibeke Lænkholm, Ashley Cimino‐Mathews, Ashok Srinivasan, Balázs Ács, Baljit Singh, Benjamin C. Calhoun, Benjamin Haibe-Kans, Benjamin Solomon, Bibhusal Thapa, Brad H. Nelson, Carlos Castaneda, Carmen Ballesteroes-Merino, Carmen Criscitiello, Carolien Boeckx and 158 more - npj Breast Cancer 2020 cited by 166

  18. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

    Authors: Dale W. Garsed, Ahwan Pandey, Sián Fereday, Catherine J. Kennedy, Kazuaki Takahashi, Kathryn Alsop, Phineas T. Hamilton, Joy Hendley, Yoke-Eng Chiew, Nadia Traficante, Pamela Provan, Dinuka Ariyaratne, George Au‐Yeung, Nicholas W. Bateman, Leanne Bowes, Alison H. Brand, Elizabeth L. Christie, Julie M. Cunningham, Michael Friedländer, Bronwyn Grout, Paul R. Harnett, Jillian A. Hung, Bryan M. McCauley, Orla McNally, Anna Piskorz, Flurina A.M. Saner, Robert A. Vierkant, Chen Wang, Stacey J. Winham, Paul D.P. Pharoah, James D. Brenton, Thomas P. Conrads, G. Larry Maxwell, Susan J. Ramus, Celeste Leigh Pearce, Malcolm C. Pike, Brad H. Nelson, Ellen L. Goode, Anna DeFazio, David D.L. Bowtell - Nature Genetics 2022 cited by 113

  19. Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer

    Authors: Céline M. Laumont, Maartje C.A. Wouters, Julian Smazynski, Nicole S. Gierc, Elizabeth A. Chavez, Lauren C. Chong, Shelby Thornton, Katy Milne, John R. Webb, Christian Steidl, Brad H. Nelson - Clinical Cancer Research 2021 cited by 105

  20. Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer

    Authors: Nikki Burdett, Madelynne O. Willis, Kathryn Alsop, Allison L. Hunt, Ahwan Pandey, Phineas T. Hamilton, Tamara Abulez, Xuan Liu, Therese Hoang, Stuart Craig, Sián Fereday, Joy Hendley, Dale W. Garsed, Katy Milne, Shreena Kalaria, Ashley Marshall, Brian L. Hood, Katlin N. Wilson, Kelly A. Conrads, Kathleen I. Pishas, Sumitra Ananda, Clare L. Scott, Yoland Antill, Orla McNally, Linda Mileshkin, Anne Hamilton, George Au‐Yeung, Lisa Devereux, Heather Thorne, Andrea H. Bild, Nicholas W. Bateman, G. Larry Maxwell, Jeffrey T. Chang, Thomas P. Conrads, Brad H. Nelson, David D.L. Bowtell, Elizabeth L. Christie - Nature Genetics 2023 cited by 86

  21. Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival

    Authors: Scott D. Brown, Robin M. Warren, Ewan A. Gibb, Spencer D. Martin, John J. Spinelli, Brad H. Nelson, Robert A. Holt - Genome Research 2014 cited by 617

  22. The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

    Authors: Christopher W. Helsen, Joanne A. Hammill, Vivian Wing Chong Lau, Kenneth A. Mwawasi, Arya Afsahi, Ksenia Bezverbnaya, Lisa Newhook, Danielle L Hayes, Craig Aarts, Bojana Bojović, Galina Denisova, Jacek M. Kwiecień, Ian Brain, Heather Derocher, Katy Milne, Brad H. Nelson, Jonathan L. Bramson - Nature Communications 2018 cited by 123

  23. Tumour immunotherapy: lessons from predator–prey theory

    Authors: Phineas T. Hamilton, Bradley R. Anholt, Brad H. Nelson - Nature reviews. Immunology 2022 cited by 91

  24. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer

    Authors: John R. Webb, Katy Milne, David R. Kroeger, Brad H. Nelson - Gynecologic Oncology 2016 cited by 341